Serum lipid and inflammatory cytokine profiles were assessed in 124 in-patients with coronary heart disease (CHD) (CHD group) and 43 inpatients with no evidence of CHD (control group). In all patients, research questionnaires and examinations of periodontal health were conducted and venous blood samples were analysed. Both groups were divided into two subgroups according to the presence or absence of chronic periodontitis in individual patients. The prevalence of chronic periodontitis was higher in patients from the CHD group than in the control group. Levels of total cholesterol, triglycerides, low-density lipoprotein, oxidized low-density lipoprotein, highsensitivity C-reactive protein, interleukin-6 and tumour necrosis factor-a were significantly higher in CHD patients with chronic periodontitis than in those without periodontitis. In conclusion, chronic periodontitis may be associated with CHD.
Introduction
In the last decade, a new branch of periodontology -'periodontal medicine'has emerged, which has drawn attention to the relationship between periodontal and systemic health or disease. 1 For example, an association between periodontal disease and coronary heart disease (CHD) has been reported, 2 -4 and in-depth research into coronary atherosclerotic heart disease has identified a growing body of evidence implicating chronic inflammation in the pathogenesis of CHD. 5 -7 In addition, microbes, including bacteria and viruses, may be predisposing factors that induce the coronary atherosclerosis process. 8, 9 Chronic periodontitis is a chronic bacterial infection of gingiva and bone, with a high global prevalence, that destroys normal oral function and morphology, 10 and also causes harm to the cardiovascular system. 11 In 1989, Mattila et al. 11 first reported that the dental health of patients who developed acute myocardial infarction (MI) was worse than that observed in healthy people of the same age and sex: multiple regression analysis K Tang, M Lin, Y Wu et al. Lipid and cytokine profiles in CHD and periodontitis showed that periodontitis was a novel risk factor for CHD independent of age, serum total cholesterol concentration, triglyceride concentration, hypertension, diabetes and history of cigarette-smoking. Their subsequent studies found that the association between CHD and chronic periodontitis remained significant, 12, 13 further supporting the hypothesis that bacterial infection played an important role in the pathogenesis of coronary atherosclerosis. Oral-cavity health was a significant predictor of coronary events and chronic periodontitis was considered a possible independent risk factor for CHD development. 12, 13 Some studies have reported that periodontal pathogens were present in atherosclerotic plaques and may be implicated in atherosclerosis development and progression, thereby leading to coronary vascular events. 14, 15 An animal study showed that atherosis formation could be enhanced when animals were exposed to periodontal pathogens. 16 The mechanisms behind the relationship between periodontitis and CHD are not fully understood. Thus, we formulated the hypothesis that periodontal infection may be associated with disturbances in lipid metabolism that lead to coronary atherosclerosis. The aim of the present study was to study the physical and periodontal condition of CHD patients and to analyse the related risk factors for CHD.
Patients and methods

PATIENTS
From September 2007 to January 2009, CHD in-patients without concomitant systemic diseases, selected from the Department of Cardiology of the First Affiliated Hospital of Fujian Medical University, were enrolled into the CHD group. Diagnosis of CHD was based on World Health Organization (WHO) criteria, namely that coronary angiography showed a ≥ 50% stable stenosis or arterial obstruction of at least one major coronary artery. 17 At the same time, subjects without major systemic diseases were randomly recruited from those undergoing physical examination at the Physical Examination Centre of the First Affiliated Hospital of Fujian Medical University, to form the control group.
Patients were excluded from the CHD or the control groups for the following reasons: other systemic diseases; history of drug allergy; and use of antibiotics, adrenal cortical hormone, non-steroidal antiinflammatory drugs, sex hormones or contraceptive drugs in the previous 3 months. Patients were also excluded if they had developed MI or undergone periodontal treatment in the previous 6 months.
The study received human ethics approval from the Ethics Committee of the School of Stomatology, Fujian Medical University, Fujian, China, and all study participants provided full informed consent for venous blood sampling and periodontal examination.
DATA COLLECTION
The following indexes were recorded for each patient in the CHD and control groups: age; sex; body mass index (a BMI > 30 kg/m 2 was considered obese); 18 history of hypertension (diagnosed according to the WHO 1978 standard for blood pressure measurement (systolic ≥ 140 mmHg and/or diastolic ≥ 90 mmHg); 19 family history of cardiovascular disease; and history of cigarette smoking. A cigarette smoker was defined as a person who smoked a mean of ≥ 1 cigarette/day for > 1 year.
PERIODONTAL EXAMINATION
All patients in the CHD and control groups underwent clinical periodontal examination K Tang, M Lin, Y Wu et al.
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by an experienced dentist (Y.W.) who recorded plaque index (PLI), sulcular bleeding index (SBI), calculus index (CI), probing depth (PD), loss of teeth (missing teeth) and attachment loss (AL).
Scores and criteria for PLI were: 0, no plaque in the gingival area; 1, a film of plaque adhering to the free gingival margin and adjacent area of the tooth, recognized only by running a probe across the tooth surface; 2, moderate accumulation of soft deposits within the gingival pocket, on the gingival margin and/or adjacent tooth surface, which can be seen by the naked eye; and 3, abundance of soft matter within the gingival pocket and/or on the gingival margin and adjacent tooth surface. 20 Scores and criteria for SBI were: 0, healthy gingival and no bleeding; 1, bleeding on probing, but no oedema and colour change on the gingival papilla and gingival margin; 2, bleeding on probing, colour change on the gingival papilla and gingival margin, but no oedema; 3, bleeding on probing, colour change and slight oedema on the gingival papilla and gingival margin; 4, bleeding on probing, colour change and obvious oedema on the gingival papilla and gingival margin; and 5, bleeding on probing and spontaneous bleeding, colour change and obvious oedema on the gingival papilla and gingival margin. 21 Scores and criteria for CI were: 0, no calculus in the surface of the teeth; 1, calculus covering less than one-third of the surface area; 2, calculus covering between one-third and two-thirds of the surface area; and 3, calculus covering more than twothirds of the surface area. 22 The PD was recorded as the depth from the bottom of the periodontal pocket to the gingival margin via periodontal probes and AL was calculated as PD ± the distance from the cemento-enamel junction to the gingival margin. 23 Peridontitis was diagnosed according to the classification of periodontal diseases and conditions described by Preus and Laurell 23 and, according to the degree of AL, was defined as mild (AL 1 -2 mm), moderate (AL 3 -4 mm), or severe (AL ≥ 5 mm).
Following these examinations, the CHD and control groups were each subdivided into two patient subgroups, according to presence or absence of periodontitis. Then the morbidity rate of periodontitis was calculated for each group (number of periodontitis patients divided by the total number of subjects from either the CHD group or the control group).
SEROLOGICAL STUDIES
Early in the morning, before breakfast, 4 ml fasting venous blood without anticoagulants was obtained from each patient following overnight fast. Some (2 ml) of this blood was sent to the Clinical Laboratory of the First Affiliated Hospital of Fujian Medical University, where serum levels of total cholesterol (TC), triglycerides (TG), highdensity lipoprotein (HDL), low-density lipoprotein (LDL), fibrinogen (Fg) and highsensitivity C-reactive protein (hs-CRP) were assessed. The other 2 ml of blood was immediately centrifuged to obtain serum, which was then stored at -70°C prior to testing and analysis. Levels of oxidized lowdensity lipoprotein (ox-LDL), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) were assessed by enzyme-linked immunosorbent assay (ELISA). All ELISA kits were supplied by Xitang Biotechnology, Shanghai, China, and were carried out according to the manufacturer's instructions.
STATISTICAL ANALYSES
Statistical analyses were carried out using the SPSS ® statistical package, version 13.0 Data presented as number of patients.
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(SPSS Inc., Chicago, IL, USA) for Windows ® . Enumeration data or sample proportions were compared by the χ 2 test. Measurement data were recorded as mean ± SD. Tukey's test was used to compare differences between two groups. A P-value < 0.05 was considered to be statistically significant.
Results
PATIENTS
The CHD group consisted of 124 patients with CHD (88 males, 36 females; mean ± SD age 56 ± 11.1 years, range 37 -82 years). Because of the difficulty in finding subjects with no evidence of CHD who fulfilled the inclusion criteria, the control group comprised only 43 patients (30 males, 13 females; mean ± SD age 54 ± 8.2 years, range 34 -78 years). Baseline data on the numbers of subjects in each group for periodontitis, cigarette smoking, hypertension, BMI and family history of cardiovascular disease are shown in Table 1 .
SEROLOGICAL AND PERIODONTAL STATUS: OVERVIEW
Mean levels of TC, TG, LDL, ox-LDL, Fg, hs-CRP, IL-6 and TNF-α were significantly higher in the CHD group compared with the control group (P < 0.05; Table 2 ). Conversely, the mean HDL level in the CHD group was lower than that in the control group (P < 0.05; Table 2 ). Periodontal examination revealed significant increases in PD, AL, SBI and the number of missing teeth in the CHD group compared with the control group (all P < 0.05), although no significant betweengroup differences in CI or PLI were identified ( Table 2) .
Serological data from the two subgroups of control subjects (i.e. with or without chronic periodontitis) revealed no statistically significant between-subgroup differences in TC, TG, HDL, LDL, ox-LDL, Fg and hs-CRP levels ( Table 3 ). Levels of IL-6 and TNF-α were significantly higher in the subgroup of controls with periodontitis compared with those without periodontitis (P < 0.05; Table 3 ).
In the subgroups of patients with CHD with or without chronic periodontitis, levels of TC, TG, LDL, ox-LDL, hs-CRP, IL-6 and TNF-α were significantly higher in patients with CHD and periodontitis than those with CHD and without periodontitis (P < 0.05; Table 4 ). Between-subgroup differences were observed in Fg and HDL levels, but these did not reach statistical significance (Table 4 ).
CHD RISK FACTORS
The morbidity rate for chronic periodontitis in the CHD group was 81.45% and for the control group was 58.13% (χ 2 = 9.367, P = 0.002; Table 5 ). A statistically significant relationship was observed between the severity of chronic periodontitis, as measured K Tang, M Lin, Y Wu et al.
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by the degree of AL, and the presence of CHD (χ 2 = 9.875, P = 0.002; Table 5 ). Multifactorial logistic regression analysis on the risk factors for CHD found that periodontitis and traditional risk factors, such as smoking, hypertension and family history of cardiovascular disease, were predictors of CHD (P < 0.05; Table 6 ).
Discussion
Many early epidemiological investigations into the link between periodontitis and CHD have been undertaken. Some have shown periodontal disease to be significantly associated with an increased risk of CHD. 24, 25 Data from an angiography study also identified a relationship between the extent of atherosclerosis and the degree of periodontal disease. 12 In the present study, the status of all patients' periodontal condition was determined by clinical periodontal assessments, including PLI, SBI, CI, PD, loss of teeth (missing teeth) and AL. These examinations showed that the severity of periodontitis in patients with CHD was greater than that seen in control subjects with periodontitis and the morbidity rate for chronic periodontitis was significantly higher in the CHD group than in the control group. There were also significant differences in SBI, PD, AL and the number of missing teeth between CHD and control groups. These findings are in accordance with those from other studies. For example, Lowe et al. 26 observed that the number of missing teeth was significantly associated with the development of cardiovascular disease. In another study, the number of missing teeth was directly related to CHD events among healthy subjects. 27 The present study showed that the risk of developing CHD increased with increasing severity of periodontitis.
Multifactorial logistic regression analysis identified periodontitis, cigarette smoking, hypertension and family history of CHD as independent risk factors for CHD development. 
Lipid and cytokine profiles in CHD and periodontitis
Hyperlipidaemia plays a vital role in CHD development, and epidemiological investigations have indicated a significant positive correlation between hyperlipidaemia-related morbidity and CHD. 28 This suggests that a disorder of lipid metabolism may be an important risk factor for CHD development and, therefore, alterations in serum lipid profiles in patients with CHD and chronic periodontitis were examined in the present study.
Blood cholesterol is a major cause of atherosclerosis and mainly exists in the form of LDL. Elevated LDL levels are essential for atherogenesis 29 and LDL promotes atherosclerosis development mainly through ox-LDL, which has been considered as a contributing factor for atherosclerosis development:
ox-LDL can promote monocyte binding to the endothelium, and induce antibody production and subsequent formation of immune complexes. 30 These immune complexes induce a marked accumulation of cholesteryl esters and the release of inflammatory cytokines, such as IL-1 and TNF-α. 30 High-density lipoprotein can resist atherosclerosis and is the protective factor for CHD because it participates in reverse cholesterol transport and eliminates the lipid component of atheromatous plaques. 31 The concentration of HDL has a significant negative correlation with the degree of artery wall stenosis. 32
TABLE 5: Comparison of the relationship between severity of chronic periodontitis, as measured by the degree of attachment loss (AL), and coronary heart disease (CHD) in patients with CHD (CHD group) and those without CHD (control group)
With chronic peridontitis
Without chronic
Mild Moderate Severe periodontitis (AL 1 -2 mm) (AL 3 -4 Statistically significant difference in morbidity for chronic periodontitis in the CHD group versus the control group (81.45% versus 58.13%; χ 2 = 9.367, P = 0.002). Statistically significant relationship between the severity of periodontitis, as measured by the degree of AL, and the presence of CHD (χ 2 = 9.875, P = 0.002). 
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Previous research has also described a significant relationship between periodontitis and elevated TC and TG levels. 33 The present study showed that serum levels of TC, TG, LDL and ox-LDL were higher in the CHD group than in the control group (patients with no CHD or other systemic diseases), and that serum HDL levels were lower in the CHD group than in the control group. In the subgroup of control patients who had chronic periodontitis, levels of TC, TG and ox-LDL were also higher than in the subgroup of control patients without chronic periodontitis, although the differences were not statistically significant. In the subgroup of patients with CHD and chronic periodontitis, however, levels of TC, TG and ox-LDL were statistically significantly higher than in CHD subgroup without chronic periodontitis. The HDL levels in this subgroup of CHD patients without periodontitis were lower than in those who had periodontitis, although this was not statistically significant. Certainly, the present study indicated a possible relationship between chronic periodontitis and impaired lipid metabolism, which is in accordance with previous reports. 34 -40 The CHD patients with chronic periodontitis in the present study had significantly higher serum concentrations of the pro-inflammatory cytokines IL-6 and TNF-α compared with CHD patients without periodontitis. The subgroup of control patients with periodontitis also had higher levels of these the pro-inflammatory cytokines than control patients without periodontitis. Based on this we suggest that chronic periodontitis may increase the risk of developing CHD by leading to the release of pro-inflammatory cytokines: these cytokines are capable of influencing lipid metabolism and increasing serum lipid levels through the action of endotoxin, 41, 42 thereby causing the generation and development of atheromatous plaques and, finally, leading to CHD.
Studies have indicated that periodontal disease is a chronic infection in which high levels of pro-inflammatory cytokines can be produced during the active phase, thereby influencing inflammatory reactions, hostdefence, and tissue damage through humoural and cell immunity function. 43 -47 Previous research has demonstrated that lipid metabolism may be altered by some proinflammatory cytokines, induced by chronic local and acute systemic infections. 30 Any condition that produces elevations in serum levels of pro-inflammatory cytokines, such as TNF-α and IL-1β, has the potential to cause hyperlipidaemia. TNF-α can induce an increase in serum triglycerides, very lowdensity lipoprotein and cholesterol levels. 48 IL-6 may even participate in the formation and development of atherosclerosis. 49 -51 Together, these studies support the hypothesis that periodontal infection may be associated with disturbances in lipid metabolism that lead to coronary atherosclerosis. 30,43 -51 Under pathophysiological conditions, CRP appears in blood and is commonly regarded as a high-sensitivity marker of inflammation and tissue damage during the inflammatory response to tissue injury or infection. 52 It plays a role in endothelial cell dysfunction and may have direct involvement in the occurrence and development of atherosclerosis. 53, 54 Consequently, CRP may be an important bridge between periodontitis and CHD. Fredriksson et al. 55 and Ebersole et al. 56 confirmed that adult patients with periodontitis had higher serum concentrations of CRP than controls: in patients with severe periodontitis, serum CRP levels were 17-fold higher than in the control group. The release of CRP is stimulated by pro-inflammatory cytokines, including IL-6. 57 Nakajima et al. 58 reported that the serum K Tang, M Lin, Y Wu et al.
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concentrations of hs-CRP and IL-6 in patients with periodontitis were significantly higher than those from subjects without periodontitis, and that periodontal treatment decreased the levels of both cytokines.
Fibrinogen is an acute phase reactant in circulating blood and elevated Fg levels is an important independent risk factor for CVD including atherosclerosis, CHD and MI. 59 Correlations between Fg levels and periodontal status have also been observed: Fg is found in settings where many putative periodontal pathogens are located and also participates in regulating inflammatory reactions in periodontal tissue. 60 In the present study, levels of hs-CRP and Fg were higher in CHD patients with chronic periodontitis than in those without chronic periodontitis, although only the increase in hs-CRP levels reached statistical significance.
The present study indicated that periodontitis may be associated with CHD, although the biological mechanisms by which chronic periodontitis could increase the risk of CHD development are not clearly established. One possible mechanism may be that some periodontal pathogens can induce local inflammation and tissue destruction, thereby stimulating the production of a variety of pro-inflammatory cytokines and immune responses. These cytokines have the potential to cause cascade reactions, manifesting as lipid metabolism disorders and vascular endothelial dysfunction which, ultimately, result in atherosclerosis and CHD. Treatments for periodontal disease have been found to have beneficial effects on lipid metabolism and CHD. For example, improved serum HDL cholesterol levels and HDL/LDL ratios were observed in patients treated for periodontitis in one study, 61 and significant decreases in serum CRP levels were observed following treatment in other studies. 62, 63 One limitation of the present study was that the number of subjects included in the control group was small. This was because of the difficulty in finding subjects with no evidence of CHD who fulfilled the inclusion criteria. Large-scale, longitudinal studies are required to investigate the relationship between periodontitis and CHD in greater detail.
Regardless of whether the relationship between periodontitis and CHD is direct or indirect, until further data are available, periodontal health should be taken into consideration when treating patients with CHD, in order to reduce morbidity levels in those patients found to have both conditions.
